Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Precision Therapeutics Appoints Kevin Hungerford as Vice President of Sales and Marketing
MINNEAPOLIS , March 12, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today that it has appointed Kevin Hungerford as Global Vice President of Sales and Marketing, effective immediately.
View HTML
Toggle Summary Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models
MINNEAPOLIS , Feb. 27, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical (NASDAQ:SKLN), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today it has formed a wholly
View HTML
Toggle Summary Precision Therapeutics, Formerly Skyline Medical, Announces Stock Ticker Symbol Change to AIPT View HTML
Toggle Summary Skyline Medical Projects 100 STREAMWAY System Sales in the U.S. in 2018
2018 projection would represent a 10x increase over 2017 sales MINNEAPOLIS , Jan. 31, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc.  (NASDAQ:SKLN) (“Skyline” or the “Company”), is pleased to announce that it currently projects sales of approximately 100 STREAMWAY Systems in 2018.
View HTML
Toggle Summary Skyline Medical Opens New European Headquarters to Drive International Sales of the STREAMWAY System
Company appoints Jean-Paul Rasschaert as Vice President of International Sales MINNEAPOLIS , Jan. 26, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc (NASDAQ:SKLN) (“Skyline” or the “Company”), today announced that it has opened new European headquarters in Belgium and appointed Jean-Paul Rasschaert
View HTML
Toggle Summary Skyline Medical Announces Corporate Name Change to Precision Therapeutics
New Name Emphasizes Company Expertise in Applying Artificial Intelligence to Personalized Medicine and Drug Discovery MINNEAPOLIS , Jan. 25, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc (NASDAQ:SKLN) (“Skyline” or the “Company”) today announced it will change its name to Precision Therapeutics Inc.
View HTML
Toggle Summary Skyline Medical Completes Purchase of Preferred Stock in Helomics Corporation
MINNEAPOLIS , Jan. 16, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ:SKLN) (“Skyline” or the “Company”), producer of the FDA -approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced it has completed the purchase of preferred stock convertible into
View HTML
Toggle Summary Skyline Medical Regains Compliance with Nasdaq's Minimum Stockholders' Equity Listing Requirements
MINNEAPOLIS , Jan. 11, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc (NASDAQ:SKLN) (“Skyline” or the “Company”), producer of the FDA -approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced that it received a letter from the Listing Qualifications Department
View HTML
Toggle Summary Helomics® Corporation Announces the appointment of Dr. Marc Malandro to its Advisory Board, providing strategic insights for the Skyline Medical – Helomics Joint Venture
PITTSBURGH , Jan. 10, 2018 (GLOBE NEWSWIRE) -- Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, today announced the addition of Marc Malandro PhD, CLP, RTTP,
View HTML
Toggle Summary Skyline Medical Announces Pricing of Firm Commitment Public Offering of Common Stock and Warrants
MINNEAPOLIS , Jan. 05, 2018 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA -approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced the pricing of a firm commitment underwritten public offering of
View HTML